Reversal of DOPA-induced arousal in reserpine-treated rabbits and mice by histidine
- PMID: 760904
- PMCID: PMC1668619
- DOI: 10.1111/j.1476-5381.1979.tb07831.x
Reversal of DOPA-induced arousal in reserpine-treated rabbits and mice by histidine
Abstract
1 The behavioural effects induced by histidine were studied in two species. In rabbits, sedation was assessed by the presence of blepharospasm, loss of righting reflex, and loss of response to painful stimuli. In mice, sedation and arousal were assessed by changes in the locomotor activity, exploratory activity, and minimal electroshock seizure threshold.2 The administration of histidine to normal rabbits or mice, in doses of 800 mg/kg and 1000 mg/kg respectively, had no apparent effect on behaviour. Moreover, it did not affect the behavioural excitation induced by L-DOPA (100 mg/kg i.v. in rabbits and 750 mg/kg i.p. in mice) in these animals.3 The administration of histidine with or after L-DOPA in reserpine-treated rabbits (2.5 mg/kg i.v.) or mice (5 mg/kg, i.p.) produced sedation. This sedative effect was dose-dependent.4 The sedative effects induced by histidine after DOPA-induced arousal in reserpine-treated rabbits and mice were prevented by prior injection of the histamine H(1)-receptor blockers, chlorpheniramine (2.5 mg/kg) or diphenhydramine (5 mg/kg).5 Imipramine (7 to 10 mg/kg, i.v.)-induced arousal in reserpine-treated rabbits was also reversed by histidine infusion.6 The infusion of 5-hydroxytryptophan (100 mg/kg, i.v.) with L-DOPA, or of arginine (450 mg/kg, i.v.) with or after L-DOPA, or of histamine (100 mug/kg), i.v.) after L-DOPA, did not affect the DOPA-induced arousal in reserpine-treated rabbits.7 These findings indicate that histamine, formed centrally from exogenous histidine, and released in increased amounts at the synapses in reserpine-treated animals, possesses a central sedative effect. This effect may be sufficient to antagonize the behavioural excitation induced by high levels of catecholamines in the brain of these animals when aroused by L-DOPA administration.8 It is concluded that in addition to the other monoamines, histamine may also be implicated in the regulation of brain excitability.
Similar articles
-
Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.Neurosci Res. 2010 Sep;68(1):44-50. doi: 10.1016/j.neures.2010.06.003. Epub 2010 Jun 11. Neurosci Res. 2010. PMID: 20542064
-
Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease.Mov Disord. 2003 Feb;18(2):138-49. doi: 10.1002/mds.10312. Mov Disord. 2003. PMID: 12539206
-
Modification of the L-DOPA reversal of reserpine akinesia by inhibitors of dopamine-beta-hydroxylase.Eur J Pharmacol. 1976 Jan;35(1):135-44. doi: 10.1016/0014-2999(76)90308-3. Eur J Pharmacol. 1976. PMID: 1253815
-
Interactions between a novel cholinergic ion channel agonist, SIB-1765F and L-DOPA in the reserpine model of Parkinson's disease in rats.J Pharmacol Exp Ther. 1997 Jan;280(1):393-401. J Pharmacol Exp Ther. 1997. PMID: 8996220
-
The medical treatment of Parkinson disease from James Parkinson to George Cotzias.Mov Disord. 2015 Jan;30(1):4-18. doi: 10.1002/mds.26102. Epub 2014 Dec 9. Mov Disord. 2015. PMID: 25491387 Review.
Cited by
-
Histamine- and haloperidol-induced catalepsy in aged mice: differential responsiveness to L-DOPA.Psychopharmacology (Berl). 2012 Sep;223(2):191-7. doi: 10.1007/s00213-012-2706-0. Epub 2012 Apr 13. Psychopharmacology (Berl). 2012. PMID: 22526536
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources